Efficacy of nivolumab (Nivo) as 2+line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: Interim results of observational prospective study.

被引：1
|
作者：
Laktionov, Konstantin K.
Arzumanyan, Alla L.
Bolotina, Larisa
Breder, Valeriy Vladimirovich
Buevich, Natalia N.
Danilova, Anastasia
Filippova, Elena A.
Kornietskaya, Anna
Kramchaninov, Mikhail M.
Kushniruk, Eugenia K.
Latipova, Dilorom H.
Moiseenko, Fedor Vladimirovich
Nikitina, Tatiana P.
Orlov, Sergey V.
Orlova, Rashida
Protsenko, Svetlana A.
Sarantseva, Ksenia A.
Stroyakovskiy, Daniil L.
Zinkovskaya, Anna V.
机构：
[1] N N Blokhin Russian Canc Res Ctr, Moscow, Russia
[2] Minist Hlth, Hertsen Moscow Oncol Res Inst, Natl Med Res Radiol Ctr, Moscow, Russia
[3] Natl Med Res Ctr Oncol n N Blokhin, Moscow, Russia
[4] N N Petrov Res Inst Oncol, St Petersburg, Russia
[5] Moscow Dept Hlth, Moscow City Oncol Hosp 62, Moscow, Russia
[6] Pavlov St Petersburg State Med Univ, R M Gorbacheva Mem Inst Children Hematol & Transp, St Petersburg, Russia
[7] St Petersburg Clin Res Ctr Specialized Types Med, St Petersburg, Russia
[8] City Clin Oncol Dispensary, St Petersburg, Russia
[9] Multinat Ctr Qual Life Res, St Petersburg, Russia
[10] St Petersburg State Univ, St Petersburg, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e21126
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21126
引用
收藏
页数：1
相关论文
共 50 条
  • [31] First-line nivolumab (NIVO) plus ipilmumab (IPI) with two cycles of chemotherapy in patients with metastatic non-small cell lung cancer (NSCLC): Results from an interim analysis of the non-interventional FINN study
    Kuon, J.
    von der Heyde, E.
    Bischoff, M.
    Wilop, S.
    Behringer, D.
    Blau, W.
    Huebner, G.
    Flieger, D.
    Forstbauer, H.
    Groschek, M.
    Laack, H.
    Mueller-Huesmann, H.
    Schumann, C.
    Waldenberger, D.
    Guetz, S.
    PNEUMOLOGIE, 2024, 78 : S102 - S103
  • [32] Phase II study of nivolumab in patients with advanced non-small cell lung cancer (NSCLC) in Korea.
    Park, Keunchil
    Cho, Eun Kyung
    Kang, Jin Hyoung
    Han, Ji-Youn
    Lee, Jong Seok
    Kim, Dong-Wan
    Kim, Sang-We
    Cho, Byoung Chul
    Min, Young Joo
    Lee, Ki Hyeong
    Kim, Joo-Hang
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (07)
  • [33] Nivolumab (nivo) plus nab-paclitaxel (nab-P) plus carboplatin (C) in patients (pts) with non-small cell lung cancer (NSCLC): Interim results from a multicenter phase I study.
    Waterhouse, David Michael
    Goldman, Jonathan Wade
    George, Ben
    O'Dwyer, Peter J.
    Ye, Moncy
    Chen, Tianlei
    Trunova, Nataliya
    Kelly, Karen
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Quality of life and survival in patients receiving chemotherapy for advanced non-small cell lung cancer (NSCLC)
    St-Pierre, D. M.
    Kreisman, H.
    Kasymjanova, G.
    Agulnik, J. S.
    Swanson, T.
    Pepe, C.
    Lajeunesse, L.
    Gagne, S.
    Dajczman, E.
    Pereira, L.
    Small, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [35] HEALTH-RELATED QUALITY OF LIFE IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) PATIENTS
    Chouaid, C.
    Mitchell, P. L. R.
    Agulnik, J.
    Herder, G. J. M.
    Lester, J. F.
    Vansteenkiste, J.
    Eriksson, J. A.
    Finnern, H. W.
    Lungershausen, J.
    VALUE IN HEALTH, 2012, 15 (04) : A227 - A227
  • [36] Quality of life in patients with advanced non-small cell lung cancer
    Bozcuk, Hakan
    Dalmis, Berna
    Samur, Mustafa
    Ozdogan, Mustafa
    Artac, Mehmet
    Savas, Burhan
    CANCER NURSING, 2006, 29 (02) : 104 - 110
  • [37] Randomized Results of Fixed-Duration (1 Year) Versus Continuous Nivolumab (nivo) in Patients (pts) with Advanced (adv) Non-Small Cell Lung Cancer (NSCLC)
    Spigel, D. R.
    McCleod, M.
    Hussein, M. A.
    Waterhouse, D. M.
    Einhorn, L.
    Horn, L.
    Creelan, B.
    Babu, S.
    Leighl, N.
    Couture, F.
    Chandler, J.
    Goss, G.
    Keogh, G.
    Garon, E. B.
    Blankstein, K. B.
    Daniel, D. B.
    Mohamed, M.
    Li, A.
    Aanur, N.
    Jotte, R.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 108 - 108
  • [38] Quality of life (QOL) and psychological support in non small cell lung cancer (NSCLC) patients: Results of a randomized trial
    Kritikos, Konstantinos
    Heras, Panagiotis
    Hatzopoulos, Antonios
    ANNALS OF ONCOLOGY, 2006, 17 : 299 - 300
  • [39] Adverse events related to nivolumab in non-small cell lung cancer (NSCLC): a retrospective observational study
    Sassier, M.
    Oulkhouir, Y.
    Gervais, R.
    Alexandre, J.
    Humbert, X.
    Coquerel, A.
    Fedrizzi, S.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 31 - 32
  • [40] The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: Results of a prospective observational study
    Dediu, Mircea
    Crisan, Emilia
    Radut, Maria
    Tarlea, Alin
    Median, Dragos
    Alexandru, Aurelia
    Vremes, Georgeta
    Gal, Cristian
    LUNG CANCER, 2009, 63 (02) : 271 - 276
12345